415697-08-4 | 2-[[4-[(4-Nitrophenyl)Methoxy]Phenyl]Methyl]-4-Thiazolidinecarboxylic Acid Ethyl Ester

Packsize	Purity	Availability	Price	Discounted Price
1mg	98%	in stock	$26.00	$18.00
5mg	98%	in stock	$53.00	$37.00
10mg	98%	in stock	$76.00	$53.00
25mg	98%	in stock	$126.00	$88.00

Description

• Catalog Number: AF60094
• Chemical Name: 2-[[4-[(4-Nitrophenyl)Methoxy]Phenyl]Methyl]-4-Thiazolidinecarboxylic Acid Ethyl Ester
• CAS Number: 415697-08-4
• Molecular Formula: C20H22N2O5S
• Molecular Weight: 402.4640799999999
• MDL Number: MFCD06798326
• SMILES: CCOC(=O)C1CSC(N1)Cc1ccc(cc1)OCc1ccc(cc1)[N+](=O)[O-]

Computed Properties

• Complexity: 513
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 28
• Hydrogen Bond Acceptor Count: 7
• Hydrogen Bond Donor Count: 1
• Rotatable Bond Count: 8
• Undefined Atom Stereocenter Count: 2
• XLogP3: 4

Literature

• Chronic nicotine exposure selectively activates a carrier-mediated release of endogenous glutamate and aspartate from rat hippocampal synaptosomes.

  Neurochemistry international 20120501

• High potency inhibition of hERG potassium channels by the sodium-calcium exchange inhibitor KB-R7943.

  British journal of pharmacology 20120401

• Vasopressin and oxytocin excite MCH neurons, but not other lateral hypothalamic GABA neurons.

  American journal of physiology. Regulatory, integrative and comparative physiology 20120401

• Na+-independent, nifedipine-resistant rat afferent arteriolar Ca2+ responses to noradrenaline: possible role of TRPC channels.

  Acta physiologica (Oxford, England) 20101101

• The Na+/Ca2+ exchange inhibitor 2-(2-(4-(4-nitrobenzyloxy)phenyl)ethyl)isothiourea methanesulfonate (KB-R7943) also blocks ryanodine receptors type 1 (RyR1) and type 2 (RyR2) channels.

  Molecular pharmacology 20090901

• A key role for dense granule secretion in potentiation of the Ca2+ signal arising from store-operated calcium entry in human platelets.

  Cell calcium 20090501

• The Na+/Ca2+ exchanger inhibitor, KB-R7943, blocks a nonselective cation channel implicated in chemosensory transduction.

  Journal of neurophysiology 20090301

• Characterization of SN-6, a novel Na+/Ca2+ exchange inhibitor in guinea pig cardiac ventricular myocytes.

  European journal of pharmacology 20071114

• Involvement of Na+/H+ exchangers in induction of cyclooxygenase-2 by vacuolar-type (H+)-ATPase inhibitors in RAW 264 cells.

  FEBS letters 20071002

• Endoplasmic reticulum is a key organella in bradykinin-triggered ATP release from cultured smooth muscle cells.

  Journal of pharmacological sciences 20070901

• Inhibitory mechanism of SN-6, a novel benzyloxyphenyl Na+/Ca2+ exchange inhibitor.

  Annals of the New York Academy of Sciences 20070301

• Electrophysiological effects of SN-6, a novel Na+/Ca2+ exchange inhibitor on membrane currents in guinea pig ventricular myocytes.

  Annals of the New York Academy of Sciences 20070301

• YM-244769, a novel Na+/Ca2+ exchange inhibitor that preferentially inhibits NCX3, efficiently protects against hypoxia/reoxygenation-induced SH-SY5Y neuronal cell damage.

  Molecular pharmacology 20061201

• The influence of sodium-calcium exchange inhibitors on rabbit lens ion balance and transparency.

  Experimental eye research 20061101

• [Characterization of SN-6, a novel exchange inhibitor and its renal protective effect].

  Clinical calcium 20040801

• The exchanger inhibitory peptide region-dependent inhibition of Na+/Ca2+ exchange by SN-6 [2-[4-(4-nitrobenzyloxy)benzyl]thiazolidine-4-carboxylic acid ethyl ester], a novel benzyloxyphenyl derivative.

  Molecular pharmacology 20040701